TOKYO and Osaka, December 22, 2022? – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, ¡°Astellas¡±), Eisai Co., Ltd. (TSE: 4523, CEO: Haruo Naito, ¡°Eisai¡±), Daiichi Sankyo Company, Limited (TSE: 4568, President : Sunao Manabe, “Daiichi Sankyo”) and Takeda Pharmaceutical Company Limited. (TSE: 4502 / NYSE:TAK, President and CEO Christophe Weber, ¡°Takeda¡±) today announced that the four companies have agreed the collaboration to reduce environmental burden in the field of pharmaceutical packaging.

Based on the agreement, the four companies will aim to promote the use of more environmentaly friendly packaging for pharmaceutical products by sharing knowledge on packaging technologies to reduce environmental burden, such as blister packs made of biomass-based plastic instead of petroleum-derived plastic, compact packaging, recycled packaging materials, and recyclable packaging materials.

Astellas, Eisai, Daiichi Sankyo, and Takeda aim to ensure that society benefits from this collaboration to harmonize corporate activities with the global environment. In the future, the four companies expect to expand this collaboration beyond the four companies by calling on other companies in order to reduce further environmental burden.

 

¡ö? Initiatives for Sustainability (Environment) of Each Company

Astellas has set “Deepen our engagement in sustainability” as one of the strategic goals in its Corporate Strategic Plan 2021. The reduction of environmental burden is one of Astellas’ priority themes within sustainability. For more information on specific initiatives, please visit our website.

Eisai established the “Eisai Environmental Management Vision” this fiscal year, and in addition to climate change countermeasures aimed at achieving carbon neutrality by fiscal 2040, Eisai has formed a medium- to long-term plan for environmental issues including efficient use of water and recycling of resources, and will work to further advance these efforts. To learn more about our environmental initiatives, please visit our website.

As a healthcare company with the Purpose ¡°to contribute to the enrichment of quality of life around the world,¡± Daiichi Sankyo considers global environmental conservation, which is the basis of life and livelihood, as a key management issue (Materiality) and promotes environmental management. For more information on specific initiatives, please visit our website.

At Takeda, ¡°Purpose-led Sustainability¡± is about creating both business and societal value through its core business. Takeda continues to reduce our operational carbon footprint and are now committed to achieving net-zero GHG emissions for scopes 1 and 2 before 2035 and for Scope 3 before 2040. For more information, see our Annual Integrated Report.